A carregar...
Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non—Small-Cell Lung Cancer
Despite the advancement of immunotherapy in advanced non–small-cell lung cancer, patients with poor performance status (PS) have been excluded from clinical trials and it is unknown if the benefit exists in this cohort. Our retrospective study showed that immunotherapy is an active regimen in patien...
Na minha lista:
| Publicado no: | Clin Lung Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7305948/ https://ncbi.nlm.nih.gov/pubmed/32089478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2020.01.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|